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Abstract
Background: Approximately 45–50 % of the recurrent pregnancy loss (RPL) remain(s) unexplained that challenges
its clinical management. Formation and development of placenta as well as angiogenesis are critical for successful
pregnancy. Vascular endothelial growth factor (VEGF) and connexin 43 (Cx43) play important roles in angiogenesis
and placenta development and aberration of these have been linked to RPL. We aimed to investigate whether the
expressions of VEGF and Cx43 were altered in the first-trimester tissues (chorionic villi and decidua) collected from
women with RPL compared to those from healthy early pregnant women.
Methods: First-trimester chorionic villi and decidua were collected from pregnant women diagnosed RPL who
ended up with surgical intervention (n = 28) in comparison to those collected from women requesting surgical
termination of their unwanted normal first-trimester pregnancies (n = 28). These two groups of women were
matched in age and gestational weeks. Tissues were analyzed for the protein and messenger ribonucleic
acid (mRNA) expressions of Cx43 and VEGF by immunohistochemistry, western blot, and quantitative reverse
transcription polymerase chain reaction (qRT-PCR).
Results: The expressions of both Cx43 and VEGF at the level of mRNA and protein in the villi and decidua from
women with RPL were significantly decreased compared with those from women with normal early pregnancy.
Conclusions: Reduction of Cx43 and VEGF expressed in the first-trimester tissues might indicate their important
roles involved in RPL and thus holds the potential to develop pharmaceutical therapies for treatment of RPL.
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Background
Recurrent pregnancy loss (RPL) refers to two or more
consecutive pregnancy losses before 20 weeks of gesta-
tion defined by the American Congress of Obstetricians
and Gynecologists (ACOG) [1, 2], and three or more
pregnancy losses defined by Royal College of Obstetri-
cians and Gynaecologists (RCOG) [3]. In China, for
women with two early pregnancy losses, clinical evalu-
ation is often recommended, and that conforms to the
opinion of ACOG committee [4]. Recurrent pregnancy
loss occurs about in 1 out of 100 pregnancies [5], caus-
ing depression, anxiety, stress and lowered self-esteem in
couples suffering from RPL [6, 7]. However, the
causes for approximately 45–50 % of the RPL patients
remain unclear and that challenges clinical manage-
ment of RPL [8].
During embryonic development, vascular endothelial
growth factor (VEGF), a signal cytokine that stimulates
vasculogenesis and angiogenesis [9], functions to create
new blood vessels [10–12]. These suggest that impair-
ment of angiogenesis and embryo development in RPL
may be related to VEGF dysregulation. However, the dir-
ect relationship between VEGF and RPL remains debat-
able. While some studies linked the polymorphisms of
VEGF gene with increased risk of RPL and decreased
expression of VEGF gene in endometrium was found
in pregnant women with unexplained RPL [13, 14].
Others found increased expressions of VEGF and
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VEGF receptor-1 (VEGFR-1) in serum and chorionic
villi were associated with early RPL [15, 16]. In this
study, we aimed to find out if VEGF expression in
the first-trimester tissues was altered in women with
RPL versus those with normal early pregnancy.
Connexin 43 (Cx43), one major component of cell-cell
gap junction facilitating small soluble molecules ex-
change [17], is involved in embryo implantation and
placenta formation. Reduced Cx43 expression may be
correlated with RPL [17, 18]. Reduced Cx43 expression
caused decreased expression of VEGF in endothelial
progenitor cells, aortic endothelial cells, and subsequent
impaired angiogenic potential [19–21]. Thus, we
hypothesized that the expression(s) of Cx43 and/or
VEGF in chorionic villi or decidua were reduced in
women with RPL compared to that expressed in normal
first-trimester tissues.
Methods
The study was approved by the Ethical Committee of
Medical Research at the International Peace Maternity
and Child Health Hospital, Shanghai, China. Written in-
formed consent forms were obtained from all subjects.
Sample collection
Between October 2012 and September 2013, 28 women
diagnosed with embryo death by ultrasound during the
first 12 weeks of pregnancy who had already experienced
two or more miscarriages were recruited. All of them
were diagnosed unexplained RPL and received surgical
intervention upon diagnosis. During surgery, the decidua
and chorionic villi were collected from them (n = 28) as
well as from women with normal early pregnancy who
requested surgical abortion for their unwanted pregnan-
cies serving as a control group (n = 28) at the same ges-
tational age. Women classified to the control group had
the history of prior healthy live births and had no abnor-
mal pregnancy history including previous miscarriage,
ectopic pregnancy, and still birth. The two groups of
women were matched in age and gestational age. From
each woman, half of the samples (decidua and chorionic
villi) were fixed in 10 % formalin, dehydrated in
upgraded ethanol, and embedded in paraffin for immu-
nostaining analysis and the other half of the samples
were snap frozen in liquid nitrogen and stored at −80 °C
for further analyses.
Immunohistochemistry
The 5 μm-thickness paraffin sections were deparaffinized
followed by rehydration in upgrading ethanol. Endogen-
ous peroxidase activity was quenched using 0.3 % hydro-
gen peroxide in tris buffered saline(TBS) for 30 min.
Epitope retrieval was performed in 0.1 M citrate buffer
(pH 6.0) using a microwave at full power for 10 min.
Sections were incubated with appropriate blocking
serum (VECTASTAIN UNIVERSAL ABC kit, VECTOR)
at room temperature for 20 min followed by incubation
with diluted mouse anti human Cx43 (Cell Signaling
Technology) or rabbit anti human VEGF (Abcam) over-
night in a humidified chamber at 4 °C. Negative controls
were included by replacing the primary antibody with
TBS. After rinsing in TBS three times with 5 min each,
sections with incubated with appropriate secondary anti-
body for 30 min at room temperature. Following rinse,
diamino-benzidine substrate (DAB kit, VECTOR, CA,
USA) was applied to the sections for 4 min. Slides were
cover-slipped and five views per section were taken
under 400X magnification. Blinded sample coding was
applied and the staining was independently evaluated by
two pathologists using a semi-quantitative immuno-
reactivity score. The staining for each sample was scored
by multiplying the percentage of positive staining (PP
value: 0: zero, 1: < 10 %, 2: 10–50 %, 3: > 50 %) with the
intensity of staining (SI value: 0: negative, 1: weak, 2:
moderate, 3: strong) [22]. The final results were gener-
ated by averaging the scores over the five views.
Western blot
About one cubic meter of the decidua and villi tissues
were minced, mixed with protease inhibitor cocktail
(Thermo Scientific), homogenized, and centrifuged at
12000 rpm in 4 °C. The concentration of total protein
was determined using a BCA assay (Sigma, CA, USA)
according to the manufacturer’s instruction. Forty mi-
crograms of protein were loaded onto gel lanes, sepa-
rated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE), and then transferred onto
polyvinylidene fluoride (PVDF) membranes (Millipore,
Bedford, MA). After incubation in blocking buffer
(Beyotime, Shanghai) at room temperature for two
hours, the membranes were then incubated overnight
with the primary antibody of Cx43 or VEGF at 4 °C.
After rinsing in TBS three times for 5 min each, the
membranes were incubated with horseradish peroxid-
ase (HRP)-conjugated secondary antibody (Abcam) for
two hours at room temperature. The signal was visual-
ized using enhanced chemiluminescence western blot-
ting detection reagents (Pierce) on FluorChem E
System Instrument. The band intensity was analyzed
using Alphaview software.
qRT-PCR
About one cubic meter of the decidua and villi were ho-
mogenized. Total RNA was isolated using TRIZOL re-
agent (Invitrogen, USA) according to the manufacturer’s
instruction. The PrimeScriptTM RT reagent kit with
genomic deoxyribonucleic acid (gDNA) Eraser (Takara,
Japan) was used to remove the genomic DNA and
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synthesized complementary DNA (cDNA). The PCR
amplification was performed on MasterCycler RealPlex 4
(Eppendorf, USA) using SYBRTM Premix Ex TaqTM II
Kit (Takara) according to the manufacturer’s instruc-
tions. The reaction mixture in a 20 μL volume contained
2 μL (100 ng) of cDNA, 1.6 μL (0.4 μM) mixture of the
forward and reverse primers (sequences listed in Table 1),
10 μL of SYBR Premix Ex Taq II (2X) and 6.4 μL of
RNase-free water. The reaction conditions were two mi-
nutes at 95 °C of initial denaturation, 40 cycles of denatur-
ation for seven seconds at 95 °C, and annealing/extension
for 30 sections at 60 °C. The cycle threshold (Ct) was de-
termined and fold changes of the interest genes relative to
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
serving as a house-keeping gene were calculated by the
formula of the 2-ΔΔCt. The qRT-PCR experiment was re-
peated three times with duplicates of each sample.
Statistical analyses
The Statistical Package for the Social Sciences (SPSS, ver-
sion 13.0) was used to perform all statistical analyses. Data
were checked for normality and equal variance. Student’s
t-test was used for parametric data, while Mann-Whitney
test was applied for non-parametric data to compare the
fold change of gene expression or immunostaining score
between the RPL group and control groups. The associ-
ation between the Cx43 and VEGF expressions was ana-
lyzed using linear correlation analysis. P < 0.05 was
considered statistically significant. The values were
presented as mean ± Standard Deviation (SD).
Results
There was no difference in age (30.3 ± 4.0 versus 28.7 ±
5.1) or gestational days (62.8 ± 8.3 versus 59.1 ± 7.6)
between the RPL and control groups.
Protein and mRNA expressions of VEGF in RPL group
versus control group
Compared to the control group, the immunoreactivity of
VEGF in either chorionic villi or decidua was dramatic-
ally reduced in RPL group than that in control group as
revealed by immunostaining (Fig. 1a, b). This is consist-
ent with the results of western blot (Fig. 1c, d). Similarly,
the level of VEGF mRNA was also significantly lower in
the PRL group than that in the control group (Fig. 1e).
The protein and mRNA expressions of Cx43 in RPL group
versus control group
We found that Cx43 was predominantly expressed in
the cytoplasm of cytotrophoblast, syncytiotrophoblast,
and decidua. Both immunohistochemistry (Fig. 2a, b)
and western blot (Fig. 2c, d) showed the protein level of
Cx43 expressed in either chorionic villi or decidua was
significantly lower in the RPL group than that in con-
trols. The expression of Cx43 mRNA showed the same
tendency of reduction in the RPL group compared to
that in the control group (Fig. 2e).
Correlation between VEGF and Cx43 expression in
chorionic villi and decidua
Both protein and mRNA expressions of VEGF and Cx43
in the chorionic villi collected from women with RPL were
positively and linearly related as revealed by western blot
Table 1 Sequences of primers used for qRT-PCR analysis
Gene
name




Fig. 1 The expression of VEGF in chorionic villi and decidua
collected from RPL women and control group. a, b The protein
expression of VEGF was assessed by immunohistochemistry
(magnification X400) and evaluated by IRS scores. The control group
exhibited a higher level of VEGF than RPL group. c, d The VEGF
protein expression was assessed by Western Blot and the band
intensity was evaluated. The VEGF protein is markedly more in the
control group than that in the RPL group. e The mRNA level of VEGF
was significantly lower in the PRL group than that in the control
group. Data were presented as mean ± standard deviation (SD).
*: P < 0.05; ***: P < 0.001
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and qRT-PCR (Fig. 3c, e), though immunohistochemical
result did not support that. In the control group, the result
from western blot, but not from immunostaining, showed
that the VEGF and Cx43 protein levels in the chorionic
villi were significantly correlated in a positive manner. In
the decidua, there was no significant correlation between
Cx43 and VEGF expressions in either RPL group (Fig. 3b,
d, f ) or control group (Fig. 4b, d, f ).
Discussion
The primary biological function of VEGF is promoting
microvessel permeability and angiogenesis. The develop-
ment of embryo needs extensive and systematic blood
vessels for supporting implantation and development,
which is impaired in RPL [23, 24]. VEGF induces endo-
thelial cell proliferation and migration while decreasing
cell apoptosis, increases vascular permeability, and accel-
erates stromal proteolysis [25]. VEGF is a critical factor
involved in the angiogenic development of fetus and pla-
centa, and embryo implantation and development, and
decidualization [26, 27]. Researchers have found in-
creased expression of VEGF and its soluble Fms-like
tyrosine kinase-1 (sFlt-1) in normal placenta develop-
ment, suggesting that VEGF signaling is essential for
vessel formation and angiogenesis in placenta and devel-
oping embryo. One of the pathological features of RPL is
dysfunctional vessel formation and angiogenesis, impli-
cating that VEGF dysregulation may be related to RPL.
Genetic study has demonstrated that angiogenesis genes
including VEGF function for maintaining normal preg-
nancy and is correlated with RPL [28]. Several VEGF-A
gene single nucleotide polymorphisms (SNPs) associated
with spontaneous abortion have also been identified [29].
Choi et al. found that the VEGF gene expression in chori-
onic villi was lower in RPL group [28]. Amirchaghmaghi
Fig. 2 The expression of Cx43 in chorionic villi and decidua
collected from RPL women and control group. a, b The protein
expression of Cx43 was measured by immunohistochemistry
(magnification X400) and evaluated by IRS scores. The control group
exhibited a higher level of Cx43 protein compared to the RPL group.
c, d The Cx43 protein expression was assessed by Western Blot and
the band intensity was evaluated. The protein level of Cx43 is
significantly higher in the control group than that in the RPL group.
e The expression of Cx43 mRNA was reduced in both villi and
decidua from the RPL group and those from the control group.
Data were presented as mean ± standard deviation (SD). *: P < 0.05;
**P < 0.01; ***: P < 0.001
Fig. 3 Relationship of Cx43 and VEGF expressed in the chorionic villi
collected from RPL women versus controls. The protein levels of
Cx43 and VEGF expressed in the chorionic villi were positively and
linearly related as revealed by western blot in both RPL group (a)
and control group (b), though the immunohistochemical result did
not find any correlation in either group (c, d). The same positive and
linear relationship was detected in the mRNA expression in the RPL
group (e), but not in the control group (f)
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et al. demonstrated that VEGF gene expression in endo-
metrial samples was lower in the RPL women compared
with that in proven fertile females. Consistent with these
findings, our work demonstrated that both mRNA and
protein levels of VEGF are reduced in RPL as compared
with those in controls. The increase in uterine vascular re-
sistance and decrease in uterine blood flow inhibited pla-
cental angiogenesis contributing to early embryonic
mortality [27]. Considering the above, we speculate that
reduced expression of VEGF in RPL patients contribute to
poor vessel formation and may result in recurrent
miscarriage.
Some studies demonstrated that reduced expression of
Cx43 might lead to vessel dysfunction and angiogenesis
impairment [19–21]. Deletion of Cx43 gene impaired
decidualization and resulted in poor angiogenesis [30].
Another study demonstrated that Cx43 mutation im-
paired decidual angiogenesis in mice with reduced ex-
pression of Cx43, but increased level of VEGF [31–33].
We found decreased expression of both VEGF and Cx43
expression in RPL, indicating that Cx43 and VEGF may
interact with each other to maintain normal placenta
structure and function during pregnancy. Placenta for-
mation is essential to the maintenance and progress of
pregnancy. A key step in this process is the fusion of
cytotrophoblasts with syncytiotrophoblasts. The syncy-
tiotrophoblast layer on the villous surface directly in-
vades the endometrium which called implantation,
rupturing maternal capillaries and thus participating in
maternal-fetal material exchange. An in vitro experiment
demonstrated that upregulation of Cx43 expression
promoted gap junctional intercellular communication
during the differentiation of cytotrophoblasts into syncy-
tiotrophoblasts [34]. Gerbaud et al. found that Cx43
accelerated trophoblast fusion process by activating pro-
tein kinase A (PKA)-dependent phosphorylation [35].
Cx43 is an important component for gap junction for-
mation in human preimplantation embryos [36]. Rma-
nathal et al. found that Cx43 played critical role in
controlling the paracrine secretions of stromal cells
under decidualization, which may alter the proliferation
and migration of endothelial cells. And that can have
impact on angiogenesis [37]. Consistent to these findings
[18], we found reduced expression of Cx43 in first-
trimester tissues from RPL patients. We speculate that
reduced expression of Cx43 may lead to abnormal em-
bryo implantation and poor angiogenesis, which may be
related to RPL occurrence.
Our correlation analyses indicate that reduced expres-
sions of Cx43 and VEGF may individually or inter-
actively play roles in the occurrence of RPL.
In this study, the expression of Cx43 and VEGF in
additional group of patients who underwent their first
unexplained missed abortions has not been analyzed. In
the further study, this group can be employed to explore
the relation between the expression of the Cx43 and
VEGF and the times they suffered unexplained missed
abortions.
Conclusions
We found that the expressions of VEGF and Cx43 are
significantly reduced in chorionic villi and decidua from
RPL women. And the reduction of both expressions may
contribute to RPL by interacting with each other to in-
fluence the angiogenesis of placenta and developing
embryo. Our study holds the potential to develop pre-
ventive or therapeutic strategies for RPL by targeting the
molecules of VEGF and Cx43.
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